Objective To evaluate the efficacy and toxicity of irinotecan combined with nedaplatin in second-line therapy of small-cell lung cancer.
目的观察伊立替康联合奈达铂二线治疗小细胞肺癌的疗效及毒副反应。
It can be used in the patients with recurrent ovarian cancer as a second or third line therapy.
尤其是对复发病人仍有效，可做为复发卵巢癌的二线或三线化疗。
In conclusion, HD-MA and HD-HPC have established a role as, second-line endocrine therapy or salvage measurement for the postmenopausal women with advanced, relapsed and refractory breast cancer.
作者认为，HD—MA和HD—HPC作为第二线内分泌治疗手段，对于晚期、复发或难治性乳腺癌是安全、有效并有其独具的优点的。
One caveat with this trial, as with any study of this kind, is that it does not take into account the possible impact of second-line therapy.
需要提醒的是，与任何一个同类的研究一样，此试验未考虑二线治疗的可能影响。
Selecting optimal second-line tyrosine kinase inhibitor therapy for chronic myeloid leukemia patients after imatinib failure: does the BCR-ABL mutation status really matter?
选择最佳的二线酪氨酸激酶抑制剂治疗伊马替尼治疗失败的慢性粒细胞白细胞患者：BCR - ABL突变状态是否真的重要？
Selecting optimal second-line tyrosine kinase inhibitor therapy for chronic myeloid leukemia patients after imatinib failure: does the BCR-ABL mutation status really matter?
选择最佳的二线酪氨酸激酶抑制剂治疗伊马替尼治疗失败的慢性粒细胞白细胞患者：BCR - ABL突变状态是否真的重要？
应用推荐